Your browser doesn't support javascript.
loading
Gleevec and Rapamycin Synergistically Reduce Cell Viability and Inhibit Proliferation and Angiogenic Function of Mouse Bone Marrow-Derived Endothelial Progenitor Cells.
Chen, Ling; Dai, Luping; Yan, Dewen; Zhou, Boya; Zheng, Wei; Yin, Jia; Zhou, Tao; Liu, Zehua; Deng, Jianxin; Wang, Rehua; Ding, Xiaorong; Chen, Junhui.
Afiliação
  • Chen L; Intervention and Cell Therapy Center, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
  • Dai L; Intervention and Cell Therapy Center, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
  • Yan D; Department of Endocrinology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Health Science Center of Shenzhen University, Shenzhen, China.
  • Zhou B; Department of Ultrasound, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
  • Zheng W; Intervention and Cell Therapy Center, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
  • Yin J; Center for Human Tissues and Organs Degeneration, Shenzhen Institutes of Advanced Technology, Chinese Academy of Science, Shenzhen, China.
  • Zhou T; Intervention and Cell Therapy Center, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
  • Liu Z; Intervention and Cell Therapy Center, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
  • Deng J; Department of Endocrinology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Health Science Center of Shenzhen University, Shenzhen, China.
  • Wang R; Department of Cardiology, Fujian Provincial Hospital of Fujian Medical University, Fuzhou, China.
  • Ding X; Nursing Department, Peking University Shenzhen Hospital, Shenzhen, China.
  • Chen J; Intervention and Cell Therapy Center, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
J Vasc Res ; 58(5): 330-342, 2021.
Article em En | MEDLINE | ID: mdl-34247157
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neovascularização Fisiológica / Sirolimo / Inibidores da Angiogênese / Proliferação de Células / Células Progenitoras Endoteliais / Mesilato de Imatinib Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neovascularização Fisiológica / Sirolimo / Inibidores da Angiogênese / Proliferação de Células / Células Progenitoras Endoteliais / Mesilato de Imatinib Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article